Literature DB >> 3409117

Acquired immune deficiency syndrome in Canada: the first 5 years of surveillance.

J Losos1, G Wells, K Elmslie, G Verveniotis, A J Clayton.   

Abstract

In the first 5 years of surveillance of reports of the acquired immune deficiency syndrome (AIDS) in Canada, from February 1982, the Laboratory Centre for Disease Control, Ottawa, was notified of 1133 cases reported through provincial ministries of health that met the case definition developed by the US Centers for Disease Control, Atlanta. Most cases (82.2%) were reported from the homosexual/bisexual risk group. Other risk groups were less frequently represented, in contrast to the experience in the United States, where a higher proportion of cases in drug abusers has been observed, and in Africa, where heterosexual spread is far more common. The presenting clinical picture and length of survival after diagnosis were similar to those reported for other countries. Differences between projected estimates of the number of AIDS cases obtained with polynomial and logistic growth models emphasize the need for solid epidemiologic data on the number of people infected with human immunodeficiency virus, the rates of transmission and the rates of progression to disease.

Entities:  

Mesh:

Year:  1988        PMID: 3409117      PMCID: PMC1268152     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  Acquired immunodeficiency syndrome: current and future trends.

Authors:  W M Morgan; J W Curran
Journal:  Public Health Rep       Date:  1986 Sep-Oct       Impact factor: 2.792

2.  AIDS in Africa: an epidemiologic paradigm.

Authors:  T C Quinn; J M Mann; J W Curran; P Piot
Journal:  Science       Date:  1986-11-21       Impact factor: 47.728

3.  Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom.

Authors:  G Marasca; M McEvoy
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-28

4.  Transmission dynamics of HIV infection.

Authors:  R M May; R M Anderson
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

5.  HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.

Authors:  E A Follett; A McIntyre; B O'Donnell; G B Clements; U Desselberger
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

6.  Mortality associated with mode of presentation in the acquired immune deficiency syndrome.

Authors:  A R Moss; G McCallum; P A Volberding; P Bacchetti; S Dritz
Journal:  J Natl Cancer Inst       Date:  1984-12       Impact factor: 13.506

7.  Acquired immune deficiency syndrome in the United States: the first 1,000 cases.

Authors:  H W Jaffe; D J Bregman; R M Selik
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

Review 8.  Treatment of patients with acquired immunodeficiency syndrome and associated manifestations.

Authors:  L D Kaplan; C B Wofsy; P A Volberding
Journal:  JAMA       Date:  1987-03-13       Impact factor: 56.272

  8 in total
  4 in total

1.  AIDS and the Family Physician: Survey of Practices in AIDS Counselling and HIV Antibody Testing.

Authors:  M L Goldstein; D G White
Journal:  Can Fam Physician       Date:  1990-08       Impact factor: 3.275

2.  HIV infection among Quebec women giving birth to live infants.

Authors:  C A Hankins; C Laberge; N Lapointe; M T Lai Tung; L Racine; M O'Shaughnessy
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

Review 3.  Universal precautions to prevent HIV transmission to health care workers: an economic analysis.

Authors:  S R Stock; A Gafni; R F Bloch
Journal:  CMAJ       Date:  1990-05-01       Impact factor: 8.262

4.  Using death certificates to estimate the completeness of AIDS case reporting in Ontario in 1985-87.

Authors:  R J Johnson; B L Montano; E M Wallace
Journal:  CMAJ       Date:  1989-09-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.